Despite guideline recommendations, evidence from randomized trials evaluating the appropriate low-density lipoprotein (LDL) cholesterol target for secondary prevention in patients with atherosclerotic ...
Aim To evaluate the effectiveness of atropine 0.01% in young premyopic and low-myopic children. Methods Children (5–9 years old) with premyopia (spherical equivalent refraction, SER+1.00 to −0.49D, n ...
Mr. Zamost was the head of communications, policy and people at Square, now known as Block, from 2015 to 2020. See more of our coverage in your search results.Encuentra más de nuestra cobertura en los ...
In September, payments firm Block Inc.XYZ-4.15%decrease; red down pointing triangle gathered 8,000 of its employees from around the globe to California for an extravaganza celebrating the company’s ...
Block, the parent company of Square and the Cash App, is conducting a major reorganization in the age of artificial intelligence, and investors are rewarding the move. The payment-technology company ...
Block (XYZ) stock surged 23% in Thursday after-hours trading after the payment technology company announced that it's cutting its staff by ~40%. Meanwhile, the company issued strong guidance for 2026 ...
Block to cut over 4,000 jobs CEO says AI has changed how a company is run Stock surges 25% after market Analysts call cuts a "seminal moment" in AI era Feb 26 (Reuters) - Block (XYZ.N), opens new tab ...
Workers describe a deteriorating culture at Block, the company behind Square and Cash App, where layoffs continue and employees are expected to use AI tools daily. “Morale is probably the worst I’ve ...
Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Neuroprotection in ...
Phase I Clinical Trial Evaluating Safety, Tolerability, and Early Activity of Exarafenib (KIN-2787), a Highly Selective Pan-RAF Inhibitor, in BRAF-Altered Solid Tumors or NRAS-Mutant Melanoma The ...
Despite guideline recommendations, evidence for the use of non–vitamin K antagonist oral anticoagulant (NOAC) monotherapy in patients with atrial fibrillation after implantation of a drug-eluting ...
Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results